NC
ASTH icon

nVerses Capital’s Astrana Health ASTH Stock Holding History

nVerses Capital’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Buy
+10,891
New +$392K 0.78% 8

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

nVerses Capital's ASTH Position: Q2 2026 in Review

nVerses Capital opened a new position in Astrana Health (ASTH) in Q2 2026: 10,891 shares worth $505K. The stake represents 0.78% of the portfolio and ranks #8 among its holdings.

156 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • nVerses Capital held 10,891 shares of Astrana Health worth $505K as of Q2 2026.
  • Astrana Health was a new nVerses Capital position in Q2 2026.
  • Astrana Health made up 0.78% of nVerses Capital's portfolio in Q2 2026, its #8 holding.
  • 156 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.